ResearcherHarbin Medical UniversityActive in the last 2 years
Daqian Xu
Matched on ORCID iD 0000-0003-0478-2997; OpenAlex author ID A5079924052. Sources: OpenAlex.
Their work
- Papers
- 3 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 14
2025: 1 paper · 2026: 2 papers
Papers 3
- A Chemotherapy Progression Decision Score for Treatment Selection After Initial Assessment in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1002/mco2.70903↗
- MMSDH facilitates ACSL4 propionylation to counteract ferroptosis upon hypoxia and impairs PDAC chemotherapy efficacy. Last author DOI 10.1038/s43018-026-01236-w↗
- Lipid metabolism reprograming by SREBP1-PCSK9 targeting sensitizes pancreatic cancer to immunochemotherapy. Co-author DOI 10.1002/cac2.70038↗
Closest collaborators
The 14 strongest of 14 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Gaopeng Li · 2 shared papers, 2026 · strength 0.43
- Paper A Chemotherapy Progression Decision Score for Treatment Selection After Initial Assessment in Pancreatic Ductal Adenoca… DOI 10.1002/mco2.70903↗
- Paper MMSDH facilitates ACSL4 propionylation to counteract ferroptosis upon hypoxia and impairs PDAC chemotherapy efficacy. DOI 10.1038/s43018-026-01236-w↗
- Yixin Zhang · 1 shared paper, 2026 · strength 0.24
- Yuan Ding · 1 shared paper, 2026 · strength 0.24
- Jieer Ying · 1 shared paper, 2026 · strength 0.24
- Weilin Wang · 1 shared paper, 2026 · strength 0.24
- Hanshen Yang · 1 shared paper, 2025 · strength 0.22
- Lihong He · 1 shared paper, 2025 · strength 0.22
- Kang Sun · 1 shared paper, 2025 · strength 0.22
- Tingbo Liang · 1 shared paper, 2025 · strength 0.22
- Xiaozhen Zhang · 1 shared paper, 2025 · strength 0.22
- Mengyi Lao · 1 shared paper, 2025 · strength 0.22
- Xueli Bai · 1 shared paper, 2025 · strength 0.22
- Peixiang Zheng · 1 shared paper, 2026 · strength 0.20
- Qimin Zhou · 1 shared paper, 2026 · strength 0.20
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.